Heshin-Bekenstein, M; Baron, S; Schulert, G; Shusterman, A; Fidel, V; Ben-Shahar, Y; Shukrun, R; Binenbaum, Y; Elhasid, R.
Neutrophils extracellular traps formation may serve as a biomarker for disease activity in oligoarticular juvenile idiopathic arthritis: a pilot study.
Arthritis Research and Therapy.
2023;
25:135.
Inoue, N; Schulert, GS.
Mouse models of systemic juvenile idiopathic arthritis and macrophage activation syndrome.
Arthritis Research and Therapy.
2023;
25:48.
Rao, S; Jing, N; Liu, X; Lorman, V; Maltenfort, M; Schuchard, J; Wu, Q; Tong, J; Razzaghi, H; Mejias, A; et al.
Spectrum of severity of multisystem inflammatory syndrome in children: an EHR-based cohort study from the RECOVER program.
Scientific Reports.
2023;
13:21005.
Verweyen, EL; Thakkar, K; Dhakal, S; Baker, E; Chetal, K; Schnell, D; Canna, S; Grom, AA; Salomonis, N; Schulert, GS.
Population-level single-cell genomics reveals conserved gene programs in systemic juvenile idiopathic arthritis.
The Journal of Clinical Investigation.
2023;
133:e166741.
Woo, JM P; Simmonds, F; Dennos, A; Son, MB F; Lewandowski, LB; Rubinstein, TB; Abel, N; Abulaban, K; Adams, A; Adams, M; et al.
Health Equity Implications of Missing Data Among Youths With Childhood-Onset Systemic Lupus Erythematosus: A Proof-of-Concept Study in the Childhood Arthritis and Rheumatology Research Alliance Registry.
Arthritis Care and Research.
2023;
75:2285-2294.
Towe, C; Grom, AA; Schulert, GS.
Diagnosis and Management of the Systemic Juvenile Idiopathic Arthritis Patient with Emerging Lung Disease.
Pediatric Drugs.
2023;
25:649-658.
Schulert, GS; Kessel, C.
Molecular Pathways in the Pathogenesis of Systemic Juvenile Idiopathic Arthritis.
Rheumatic Disease Clinics of North America.
2023;
49:895-911.
Shakoory, B; Geerlinks, A; Wilejto, M; Kernan, K; Hines, M; Romano, M; Piskin, D; Ravelli, A; Sinha, R; Aletaha, D; et al.
The 2022 EULAR/ACR Points to Consider at the Early Stages of Diagnosis and Management of Suspected Haemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome (HLH/MAS).
Arthritis and Rheumatology.
2023;
75:1714-1732.
Shakoory, B; Geerlinks, A; Wilejto, M; Kernan, K; Hines, M; Romano, M; Piskin, D; Ravelli, A; Sinha, R; Aletaha, D; et al.
The 2022 EULAR/ACR points to consider at the early stages of diagnosis and management of suspected haemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/MAS).
Annals of the Rheumatic Diseases.
2023;
82:1271-1285.
Chen, L; Mamutova, A; Kozlova, A; Latysheva, E; Evgeny, F; Latysheva, T; Savostyanov, K; Pushkov, A; Zhanin, I; Raykina, E; et al.
Comparison of disease phenotypes and mechanistic insight on causal variants in patients with DADA2.
Journal of Allergy and Clinical Immunology.
2023;
152:771-782.
Rai, S; Schulert, GS; Towe, C.
New developments related to lung complications in pediatric rheumatic disease.
Current Opinion in Rheumatology.
2023;
35:273-277.
Mansfield, LM; Lapidus, SK; Romero, SN; Moorthy, LN; Adler-Shohet, FC; Hollander, M; Cherian, J; Twilt, M; Lionetti, G; Mohan, S; et al.
Increase in pediatric recurrent fever evaluations during the first year of the COVID-19 pandemic in North America.
Frontiers in Pediatrics.
2023;
11:1240242.
Roberts, JE; Williams, K; Dallas, J; Eckert, M; Huie, L; Smitherman, E; Soulsby, WD; Zhao, Y; Son, MB F; Abel, N; et al.
Insurance Status and Tumor Necrosis Factor Inhibitor Initiation Among Children With Juvenile Idiopathic Arthritis in the CARRA Registry.
The Journal of rheumatology.
2023;
50:1047-1057.
Smitherman, EA; Chahine, RA; Beukelman, T; Lewandowski, LB; Rahman, AK M F; Wenderfer, SE; Curtis, JR; Hersh, AO; Abel, N; Abulaban, K; et al.
Childhood-Onset Lupus Nephritis in the Childhood Arthritis and Rheumatology Research Alliance Registry: Short-Term Kidney Status and Variation in Care.
Arthritis Care and Research.
2023;
75:1553-1562.
De Benedetti, F; Grom, A; Brogan, P; Bracaglia, C; Pardeo, M; Marucci, G; Eleftheriou, D; Papadopoulou, C; Schulert, G; Quartier, P; et al.
OP0166 LONG-TERM FOLLOW-UP OF PATIENTS ADMINISTERED EMAPALUMAB, AN ANTI–INTERFERON-Γ MONOCLONAL ANTIBODY, TO TREAT MACROPHAGE ACTIVATION SYNDROME (MAS) SECONDARY TO SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS (SJIA).
2023;
110-111.
Ruperto, N; Foeldvari, I; Alexeeva, E; Aktay Ayaz, N; Schulert, G; Özen, S; Popov, A; Ramanan, A; Scott, C; Sozeri, B; et al.
POS0278 EFFICACY AND SAFETY OF SECUKINUMAB IN JUVENILE IDIOPATHIC ARTHRITIS: INTERIM RESULTS FROM THE EXTENSION OF THE JUNIPERA TRIAL.
2023;
379.2-37380.
De Benedetti, F; Grom, AA; Brogan, PA; Bracaglia, C; Pardeo, M; Marucci, G; Eleftheriou, D; Papadopoulou, C; Schulert, GS; Quartier, P; et al.
Efficacy and safety of emapalumab in macrophage activation syndrome.
Annals of the Rheumatic Diseases.
2023;
82:857-865.
Kuhn, KA; Stahly, A; Konig, MF; Carandang, K; Herndon, C; Backman, C; Callahan, LF; Schulert, G; Fraenkel, L; Ogdie, A.
Impact of the COVID-19 Pandemic on Early Career Investigators in Rheumatology: Recommendations to Address Challenges to Early Research Careers.
Arthritis Care and Research.
2023;
75:947-955.
Vega-Fernandez, P; Ting, TV; Mar, DA; Schapiro, AH; Deluna, MD; Saper, VE; Grom, AA; Schulert, GS; Fairchild, RM.
Lung Ultrasound in Children With Systemic Juvenile Idiopathic Arthritis-Associated Interstitial Lung Disease.
Arthritis Care and Research.
2023;
75:983-988.
Jhaveri, R; Webb, R; Razzaghi, H; Schuchard, J; Mejias, A; Bennett, TD; Jone, PN; Thacker, D; Schulert, GS; Rogerson, C; et al.
Can Multisystem Inflammatory Syndrome in Children Be Managed in the Outpatient Setting? An EHR-Based Cohort Study From the RECOVER Program.
Journal of the Pediatric Infectious Diseases Society.
2023;
12:159-162.
Ringold, S; Dennos, AC; Kimura, Y; Beukelman, T; Shrader, P; Phillips, TA; Kohlheim, M; Schanberg, LE; Yeung, RS M; Horton, DB; et al.
Disease Recapture Rates After Medication Discontinuation and Flare in Juvenile Idiopathic Arthritis: An Observational Study Within the Childhood Arthritis and Rheumatology Research Alliance Registry.
Arthritis Care and Research.
2023;
75:715-723.
Shiff, NJ; Shrader, P; Correll, CK; Dennos, A; Phillips, T; Beukelman, T; Abel, N; Abulaban, K; Adams, A; Adams, M; et al.
Trajectories of disease activity in patients with JIA in the Childhood Arthritis and Rheumatology Research Alliance Registry.
Rheumatology.
2023;
62:804-814.
Teoh, Z; Danziger-Isakov, L; Courter, JD; Frenck, RW; Grimley, MS; Marsh, RA; Paulsen, GC; Phillips, CL; Spearman, P; Chima, RS; et al.
Tocilizumab for Treatment of Children and Young Adults With Severe Acute COVID-19: Experience at a Quaternary-care Children's Hospital.
The Pediatric Infectious Disease Journal.
2023;
42:119-121.
Macaraeg, M; Schulert, GS.
Complications of complications: diagnosis and treatment of recurrent macrophage activation syndrome in a patient with well-controlled systemic juvenile idiopathic arthritis.
RMD Open.
2023;
9:e002611.
Borgia, RE; Gurka, MJ; Filipp, SL; Elder, M; Cardel, M; Shiff, NJ; Abel, N; Abulaban, K; Adams, A; Adams, M; et al.
Race, ethnicity and patient-reported outcomes in childhood-onset systemic lupus erythematosus.
Clinical and Experimental Rheumatology.
2023;
41:186-194.
Smitherman, EA; Chahine, RA; Bitencourt, N; Rahman, AK M F; Lawson, EF; Chang, JC; Abel, N; Abulaban, K; Adams, A; Adams, M; et al.
Patient-Reported Outcomes Among Transition-Age Young Adults With Juvenile Idiopathic Arthritis in the Childhood Arthritis and Rheumatology Research Alliance Registry.
The Journal of rheumatology.
2023;
50:98-106.
Brunner, HI; Foeldvari, I; Alexeeva, E; Ayaz, NA; Calvo Penades, I; Kasapcopur, O; Chasnyk, VG; Hufnagel, M; Zuber, Z; Schulert, G; et al.
Secukinumab in enthesitis-related arthritis and juvenile psoriatic arthritis: a randomised, double-blind, placebo-controlled, treatment withdrawal, phase 3 trial.
Annals of the Rheumatic Diseases.
2023;
82:154-160.